Innealta Capital’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Innealta Capital’s Portfolio XLV Stock Details XLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.06M	Sell	27,675 -39,195	-59%	-$6.05M	2.52%	11
2025 Q4	$10.4M	Hold	66,870	–	–	5.6%	5
2025 Q3	$9.31M	Sell	66,870 -5,521	-8%	-$747K	4.65%	6
2025 Q2	$9.76M	Buy	72,391 +21,801	+43%	+$2.94M	5.15%	4
2025 Q1	$7.39M	Sell	50,590 -829	-2%	-$120K	4%	6
2024 Q4	$7.07M	Sell	51,419 -8,117	-14%	-$1.19M	3.44%	7
2024 Q3	$9.17M	Sell	59,536 -7,137	-11%	-$1.08M	3.72%	6
2024 Q2	$9.72M	Buy	66,673 +7,538	+13%	+$1.08M	3.21%	6
2024 Q1	$8.74M	Buy	59,135 +13	+0%	+$1.86K	3.69%	7
2023 Q4	$8.06M	Sell	59,122 -21,708	-27%	-$2.82M	3.62%	5
2023 Q3	$10.4M	Sell	80,830 -10,318	-11%	-$1.37M	4.59%	5
2023 Q2	$12.1M	Sell	91,148 -21,450	-19%	-$2.83M	4.74%	4
2023 Q1	$14.6M	Sell	112,598 -8	-0%	-$1.04K	6.16%	3
2022 Q4	$15.3M	Sell	112,606 -12,490	-10%	-$1.66M	7.11%	3
2022 Q3	$15.2M	Sell	125,096 -6	-0%	-$773	8.14%	2
2022 Q2	$16M	Buy	125,102 +65,791	+111%	+$8.62M	8.23%	3
2022 Q1	$8.13M	Sell	59,311 -7,345	-11%	-$972K	4.74%	5
2021 Q4	$9.39M	Buy	66,656 +3,553	+6%	+$472K	4.66%	4
2021 Q3	$8.03M	Buy	63,103 +30,356	+93%	+$4.01M	4.5%	5
2021 Q2	$4.12M	Sell	32,747 -456	-1%	-$55.9K	2.1%	19
2021 Q1	$3.88M	Sell	33,203 -52,945	-61%	-$6.11M	2.36%	17
2020 Q4	$9.77M	Buy	86,148 +19,658	+30%	+$2.15M	5.76%	6
2020 Q3	$7.01M	Sell	66,490 -40,271	-38%	-$4.24M	4.57%	8
2020 Q2	$10.7M	Buy	106,761 +22,341	+26%	+$2.2M	7.33%	2
2020 Q1	$7.74M	Buy	84,420 +28,661	+51%	+$2.78M	5.98%	4
2019 Q4	$5.68M	Buy	55,759 +54	+0.1%	+$5.19K	3.79%	8
2019 Q3	$5.02M	Buy	55,705 +32,452	+140%	+$2.96M	4.43%	5
2019 Q2	$2.15M	Sell	23,253 -11,066	-32%	-$995K	1.36%	25
2019 Q1	$3.15M	Buy	34,319 +8,189	+31%	+$738K	1.88%	22
2018 Q4	$2.26M	Buy	+26,130	New	+$2.36M	1.48%	25

Other funds holding XLV

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

Innealta Capital's XLV Position: Q1 2026 in Review

Innealta Capital reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 59% in Q1 2026, selling an estimated $6.05M and leaving 27,675 shares worth $4.06M. The position accounts for 2.52% of the portfolio, ranked #11.

Innealta Capital first reported a position in XLV in Q4 2018 and has held it in 30 quarters since. The position peaked at $16M in Q2 2022. 1,807 funds tracked by Wall St. Rank hold XLV as of Q1 2026.

Innealta Capital held 27,675 shares of State Street Health Care Select Sector SPDR ETF worth $4.06M as of Q1 2026.
Innealta Capital sold 39,195 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $6.05M.
State Street Health Care Select Sector SPDR ETF made up 2.52% of Innealta Capital's portfolio in Q1 2026, its #11 holding.
Innealta Capital first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2018 and has held it in 30 quarters since.
Innealta Capital's State Street Health Care Select Sector SPDR ETF position peaked at $16M in Q2 2022.
1,807 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.

Based on Innealta Capital's 13F filing for Q1 2026, filed 4 May 2026.